Delivery Order SPE2DB20D1110-SPE2DB25FK39Y
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $1,861.15. This firm fixed-price delivery order, which is due for completion by September 4, 2025, represents a continuation of AmerisourceBergen's role as a pharmaceutical supplier to the federal government. The award carries no set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Jardiance 25 mg tablets (30-count packaging) under a firm fixed-price contract valued at $2,260.38. This non-set-aside competitive award is classified as a delivery order, with an ultimate completion date of July 29, 2025. The pharmaceutical distributor will perform this work at its corporate headquarters location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $51,243.85. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Jardiance 25 mg tablets in a 90-count package. This firm fixed-price delivery order, valued at $106,293.56, is scheduled for completion by August 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a contract ceiling value of $23,977.17. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The order is scheduled for completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units) valued at $3,784.87. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $6,657.98. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for completion by September 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $35,131.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a direct supply of the diabetes medication to support federal medical procurement needs. The contract was competitively awarded with no set-aside designation, and performance will be executed from AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $10,745.91. This firm fixed-price delivery order is set to be completed by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed price contract with a ceiling value of $12,892.13. This non-competitive, non-set-aside delivery order is scheduled for completion by August 12, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK39YDelivery Order
The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Jardiance 25 mg tablets in a 90-count package, with a contract ceiling value of $76,202.50. This firm fixed-price delivery order is set to complete by September 11, 2025, and will be fulfilled from the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a pharmaceutical procurement supporting the federal government's medical supply needs, specifically for this diabetes management medication. This delivery order falls under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as a comprehensive vehicle for pharmaceutical and medical supply distribution across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor and critical vendor in the federal medical procurement landscape, AmerisourceBergen Drug Corp regularly fulfills competitive, non-set-aside delivery orders for brand-name and generic medications, vaccines, and specialized medical commodities supporting military and veteran healthcare worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $76.2k | 9/10/25 |